Inclusion body myositis (IBM) is an autoimmune myopathy that occurs mainly in people older than 50 years of age. The pathogenesis is not completely understood, but if thought to involve an interplay between inflammatory and degenerative pathways. No specific pharmacological therapy has been proven to be beneficial for sporadic inclusion body myositis. This activity describes the pathophysiology, evaluation, and management of inclusion body myositis and stresses the role of the interprofessional team in the care of affected patients.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/23434
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABOHNS - 1.0 Point; Credit Type(s): Self-Assessment (ABOHNS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Gastroenterology, General Otolaryngology, General Surgery, Internal Medicine, Neuropathology (incl. Neuromuscular), Rheumatology, Soft Tissue & Bone
Subscribe
Login
0 Comments
Oldest